Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
109–144
Headlines
551
Sources here
4
Companies here
24
Current section Brazil Healthcare news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Wall Street Analysts See a 28.2% Upside in BioMarin (BMRN): Can the Stock Really Move This High?

BioMarin Pharmaceutical (BMRN) closed the last trading session at $69.55, gaining 18.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

B1MR34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +3.3% · Next-week setup negative 37.8% B1MR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DaVita Community Care Report 2025: Creating a Culture of Belonging for All

NORTHAMPTON, MA / ACCESS Newswire / August 12, 2026 / Working Together, Working for Better At DaVita, people are the foundation of our community and the driving force behind our pursuit of a healthier tomorrow for all. Rooted in our identity as a community …

DVAI34 main company
Sharemaestro market context Trend signal active 52 weeks +17.3% DVAI34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mark Cuban on Monday urged investors to pressure major U.S. health insurers to address healthcare costs, calling on funds that hold shares in the industry to consider …

UNHH34 mentioned H1UM34 mentioned C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +26.7% UNHH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABTT34 main company
Sharemaestro market context Price above Trend Line 52 weeks -21.9% ABTT34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

U.K. regulator reaffirms safety of childhood vaccination

[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed the safety of pediatric vaccination, noting it remains one of the …

B1NT34 mentioned M1RN34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -22.7% B1NT34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IQV Stock Gains 42% in 3 Months: Here's What You Should Know

IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the Zacks S&P 500 Composite's 3.4% uptick. 3-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us …

I1QV34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +1.9% · Next-week setup negative 23.7% I1QV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

New study from CVS Caremark and Employee Benefit News shows how employers rely on their pharmacy benefit manager to create sustainable pharmacy solutions

Key opportunities include: managing GLP-1s, encouraging biosimilar substitution and employing technology to simplify and personalize the member experience WOONSOCKET, R.I., Aug. 12, 2026 /PRNewswire/ -- CVS Caremark, part of CVS Health® (NYSE: CVS), today announced the findings of a survey conducted in partnership with …

CVSH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +33.6% CVSH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of "Crowding Out Competitors" is strategically smart. Analyst Suraj Kalia said the change reflects "a more nuanced risk-reward assessment at …

I1SR34 main company JNJB34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Canada Nickel Announces Non-Brokered Private Placement for Gross Proceeds of C$15 Million

Canada Nickel logo /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Aug. 12, 2026 /CNW/ -- Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV:CNC) is pleased to announce that it intends to complete a …

C1NC34 mentioned
Sharemaestro market context Trend signal active 52 weeks +117.4% C1NC34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

I1SR34 main company JNJB34 mentioned MDTC34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and pharmaceutical markets. The investment reflects Astorg's focused healthcare strategy and distinctive approach to complex transactions, combining deep sector expertise, …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What Could HCA Healthcare (HCA) Union Protests Mean For Pay And Staffing?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. HCA Healthcare (NYSE:HCA) is facing nationwide union led protests as workers press for higher wages and improved staffing during ongoing contract negotiations. Union organizers …

H1CA34 main company
Sharemaestro market context Price below Trend Line 52 weeks -1.4% H1CA34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

4 Outperforming Stocks That Could Keep Rewarding Investors

The S&P 500 Index (SPX) is up about 13% on the year, and a surprising number of stocks have already doubled in value. Investors tend to get drawn to these high-flying stocks, which made me curious whether these stocks tend to keep going higher …

M1RN34 mentioned
Sharemaestro market context Trend signal active 52 weeks +95.6% M1RN34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Keurig Dr Pepper Announces Appointment of New Director to its Board

FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors, effective August 14, 2026. Alt brings deep expertise in finance, capital allocation …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass., August 12, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors

Madrigal Pharmaceuticals, Inc. CONSHOHOCKEN, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced it has appointed John C. Reed, M.D., Ph.D., to its Board of Directors. …

JNJB34 mentioned
Sharemaestro market context Trend signal active 52 weeks +40.9% · Next-week setup negative 44.7% JNJB34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Arbutus Biopharma Corporation Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026 Received first payment of approximately $178M from Moderna settlement in July and expects to return up to approximately $230M in capital to Arbutus …

PFIZ34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +4.1% PFIZ34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001

IDP-001 is a bispecific antibody-drug conjugate targeting EGFR and a novel Tumor-Associated Proximity Antigen identified through InduPro's proximity-guided platform Phase 1 study is enrolling adults with advanced squamous non-small cell lung cancer and other solid tumors Financing led by The Column Group, with participation …

LILY34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Company News for Aug 12, 2026

Fermi Inc. (FRMI) shares climbed 21.1% after signing a $6.5 billion lease agreement with AI cloud provider TensorWave. Aramark (ARMK) shares rose 8.5% after the company reported third-quarter 2026 earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. Plug …

C1AH34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030

Company Logo Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific's Q2 2026 revenue beat, Hamamatsu Photonics' launch of its dedicated Lasers & Fibers Business Unit, and BD's $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Bio-Techne Posts Q4 Net Profit As Expenses Drop, Net Sales Improve

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments, and services, on Wednesday reported net profit for the fourth quarter of fiscal 2026. For the three-month period to June 30, the company posted net profit of $54.622 million, or $0.35 per …

T1CH34 main company
Sharemaestro market context Trend signal active 52 weeks +39.6% · Next-week setup negative 26.2% T1CH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

UnitedHealth declares $2.32 dividend

* UnitedHealth (UNH [https://seekingalpha.com/symbol/UNH]) declares $2.32/share quarterly dividend [https://seekingalpha.com/pr/20616162-unitedhealth-group-board-authorizes-payment-of-quarterly-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/UNH/dividends/yield?source=news_bullet] 2.31% * Payable Sept. 22; for shareholders of record Sept. 14; ex-div Sept. 14. * See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/UNH/dividends?source=news_bullet] MORE ON …

UNHH34 main company
Sharemaestro market context Trend signal active 52 weeks +26.7% UNHH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

August 12, 2026--(BUSINESS WIRE)--The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on September 22, 2026, to all shareholders of record of UNH common stock as of the close of business …

UNHH34 main company
Sharemaestro market context Trend signal active 52 weeks +26.7% UNHH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Lilly files six lawsuits to crack down on black market retatrutide weight-loss shots

[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Lilly escalated its fight against black-market retatrutide by filing six new lawsuits against U.S. sellers, including compounding pharmacies, medical spas, and online vendors, the drugmaker said Wednesday in a statement [https://seekingalpha.com/pr/20616057-lilly-calls-on-online-platforms-payment-companies-and-regulators-to-shut-down-the-illegal]. The company said retatrutide …

LILY34 main company
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Files six new lawsuits as company escalates fight to protect patients INDIANAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today escalated its continued fight to protect patients from the dangerous black market for retatrutide, filing six new lawsuits against U.S. …

LILY34 main company
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

If I Were in My 40s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever

Key Points Warren Buffett steered the Berkshire Hathaway holding company to market-crushing returns for 60 years. He often said everyday investors could do well by simply buying an exchange-traded fund that tracks a diversified index like the S&P 500. In February 2014, he specifically …

LILY34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD

New Site Will Support Global Research and Development Capabilities and Advance Scientific Research HYDERABAD, India, Aug. 12, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans to open a new Science and Innovation Center at Genome Valley in Hyderabad. The center will join Amgen's …

AMGN34 main company
Sharemaestro market context Trend signal started 52 weeks +36.5% AMGN34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Align Technology Prevails in China Patent Infringement Action

Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system Silver Upgrade to read this MT …

A1LG34 main company
Sharemaestro market context Price below Trend Line 52 weeks +15.1% · Next-week setup negative 41.3% A1LG34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stock futures little changed as traders await inflation report

[Wall Street-Street Sign] P_Wei/E+ via Getty Images Stock index futures were muted on Wednesday as traders turned their attention to a closely watched consumer inflation report that could offer fresh clues on the Federal Reserve's policy path. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.01%, S&P 500 …

A1GI34 mentioned
Sharemaestro market context Trend signal started 52 weeks +14.6% · Next-week setup negative 27.8% A1GI34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH

(RTTNews) - The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports. Alamar Biosciences Inc. (ALMR) Alamar Biosciences is a proteomics company that has develops a liquid biopsy platform …

C1AH34 mentioned D1EX34 mentioned
Sharemaestro market context Trend signal active 52 weeks +41.7% · Next-week setup negative 29.0% C1AH34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?

Absci Corporation recently reported second-quarter 2026 results showing a net loss of US$33.21 million, wider than a year ago, while basic and diluted loss per share from continuing operations narrowed to US$0.21. Alongside these figures, Absci highlighted encouraging early Phase 1 data for ABS-201, …

LILY34 mentioned
Sharemaestro market context Trend signal active 52 weeks +61.5% LILY34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses

Cystic fibrosis investors came to learn a harsh lesson on August 10 about how concentrated a market can be: Sionna Therapeutics, Inc. (NASDAQ:SION) shares fell more than 90% following a key trial failure, while Vertex Pharmaceuticals (NASDAQ:VRTX), the company whose drug dominance Sionna was …

VRTX34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +17.4% · Next-week setup positive 55.7% VRTX34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context